Teimuraz Apridonidze

Teimuraz Apridonidze was an Instructor in Medicine at Memorial Sloan Kettering Cancer Center (MSKCC), affiliated with the Department of Medicine and Cardiology divisions. His research focused on cardiac amyloidosis, particularly the role of troponin as a prognostic marker in amyloid light-chain (AL) cardiac amyloidosis. He investigated clinical, echocardiographic, and biochemical correlates of elevated troponin levels in patients with CAL, demonstrating its strong predictive value for survival outcomes.

Key contributions include studies on cardiac structure/function abnormalities linked to AL amyloidosis and left atrial remodeling in CAL. His work highlights the importance of troponin in clinical assessment and prognosis, with findings published in journals like the American Journal of Cardiology and Amyloid. He collaborated extensively with teams at MSKCC, focusing on hematology and oncology-related cardiac complications.

No formal awards or grants are listed in available records. He was part of interdisciplinary groups including the Division of Subspecialty Medicine and Bone Marrow Transplant teams.